Jan 4 (Reuters) - Alpha Healthcare Acquisition Corp III
ALPA.O :
* ALPHA HEALTHCARE ACQUISITION CORP III - ANNOUNCED
EXECUTION OF
DEFINITIVE BUSINESS COMBINATION AGREEMENT WITH CARMELL
THERAPEUTICS CORPORATION
* ALPHA HEALTHCARE ACQUISITION CORP III - UPON CLOSING OF
TRANSACTION, ALPA WILL BE RENAMED CARMELL THERAPEUTICS
CORPORATION
* ALPHA HEALTHCARE ACQUISITION CORP III - RANDY HUBBELL WILL
SERVE
AS CHIEF EXECUTIVE OFFICER OF COMBINED COMPANY
* ALPHA HEALTHCARE ACQUISITION CORP III - COMBINED CO’S
COMMON
STOCK IS EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL
CTCX
* ALPHA HEALTHCARE ACQUISITION CORP III - COMBINED CO IS
EXPECTED
TO RECEIVE GROSS PROCEEDS OF ABOUT $154 MILLION AT CLOSING OF
TRANSACTION
Further company coverage: ALPA.O
((Reuters.Briefs@thomsonreuters.com;;))